Clinical trials have formed the foundation of virtually every advance made in cancer care. Trials can offer hope when standard therapies are no longer effective. MSK Kids offers a range of clinical trials assessing investigational approaches for children with Hodgkin lymphoma and non-Hodgkin lymphoma. We have trials for cancer that has continued growing or has come back after treatment. These include studies assessing immunotherapies. These treatments boost the power of the immune system to find and kill cancer cells. We also study new drugs and stem cell transplantation techniques.
At MSK Kids, we are offering CAR T cell immunotherapy to patients under age 18 with B-cell non-Hodgkin lymphoma through a clinical trial. With CAR T cell therapy, white blood cells called T cells are removed from the patient. The cells are altered in a laboratory to recognize a protein on the cancer cells. They are then multiplied to larger numbers and returned to the patient, where they find and destroy cancer cells.
Your child’s care team will let you know if your child can participate in a clinical trial. The decision to enroll is entirely voluntary. The study team will explain the benefits and risks of the study to you so you can make an informed decision.